Tampere University Hospital
Tampere, 33521, Finland
NCT Number: NCT00534534
Retrospective studies have shown, that about half of the patients will have a recurrent episode after the first acute alcoholic pancreatitis. Of the patients in hospital, more than half annually are treated for recurrent acute pancreatitis. Because alcohol has been shown an important factor in the development of recurrent pancreatitis, it was hypothesized, that by attempting intensively to diminish the individual alcohol consumption the number of recurrent pancreatitis could be decreased. Two protocols will be compared: A) initial intervention against alcohol abuse and B) repeated interventions at 6 month intervals.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Tampere, 33521, Finland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All these patients will be advised, i.e. undergo "behavioural intervention", against alcohol use in the standard fashion as those in the standard group. No drugs will be used as part of the intervention. They also will undergo repeated interventions at outpatient visits at 6 mo intervals. They are re-examined at two years for alcohol consumption and for the number of recurrent pancreatitis during the two year period.
Time frame: 2 years
Time frame: 2 years
Tampere University
Other
Randomized Clinical Trial of the Effect of Standard Versus Intensive Intervention Protocol in Attempting to Reduce Recurrent Episodes of Acute Alcoholic Pancreatitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00444444
Autoimmune Diseases, Autoimmune Pancreatitis
Seoul, South Korea
View Trial DetailsNCT03253861
Acute Necrotizing Pancreatitis, Digestive System Diseases
Nantes, France
View Trial DetailsNCT07599605
Digestive System Diseases, ERCP
Chihuahua City, Chihuahua, Mexico
View Trial DetailsNCT06721572
Abdominal Pain, Chronic Disease
Ann Arbor, Michigan, United States
View Trial Details